ZR2 Bioenergy

Why is ZR2 Bioenergy Ltd falling/rising?

As of 23-Jun, ZR2 Bioenergy Ltd's stock price is at 117.50, down 0.42%, with significant declines of 59.48% year-to-date and 69.48% over the past year, underperforming the Sensex. The stock is in a bearish trend, trading below all moving averages, and has seen a notable drop in investor participation.

As of 23-Jun, ZR2 Bioenergy Ltd's stock price is currently at 117.50, reflecting a decrease of 0.5, or 0.42%. The stock has shown a significant decline over various time periods, with a year-to-date drop of 59.48% and a one-year decline of 69.48%. This performance is notably worse than the benchmark Sensex, which has only fallen by 10.58% year-to-date.<BR><BR>In the past week, ZR2 Bioenergy has decreased by 3.29%, while the Sensex has only dropped by 0.79%. Over the past month, the stock has plummeted by 21.67%, contrasting sharply with the Sensex's increase of 1.04%. Furthermore, the stock is trading below all its moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend.<BR><BR>Investor participation has also declined, with delivery volume on 19 June falling by 76.45% compared to the 5-day average, suggesting reduced interest in trading the stock. Despite outperforming its sector by 0.57% today, the overall trend and significant declines in both stock price and investor engagement indicate that ZR2 Bioenergy Ltd is currently experiencing a downward movement in its stock price.

Which are the latest news on ZR2 Bioenergy?

How big is ZR2 Bioenergy?

As of 10th June, ZR2 Bioenergy Ltd has a market capitalization of 217.00 Cr, with net sales of 0.00 Cr and a net profit of 1.01 Cr reported in the latest four quarters. Shareholder's funds are 139.34 Cr, and total assets amount to 139.50 Cr as of March 2025.

As of 10th June, ZR2 Bioenergy Ltd has a market capitalization of 217.00 Cr and is classified as a Micro Cap company.<BR><BR>In the latest four quarters, ZR2 Bioenergy reported net sales of 0.00 Cr and a net profit of 1.01 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with shareholder's funds amounting to 139.34 Cr and total assets of 139.50 Cr.

Who are in the management team of ZR2 Bioenergy?

The management team of ZR2 Bioenergy includes Chairman Sagar Shah, Company Secretary Sangeeta Khyani, Independent Directors Barkha Balkrushnan Deshmukh and Sunil Kondiba Kalhapure, Whole-time Director Viraj Samirbhai Shah, and Non-Executive Director Rajasvee Shah.

The management team of ZR2 Bioenergy includes the following members:<BR><BR>1. **Sagar Shah** - Chairman (Non-Executive)<BR>2. **Sangeeta Khyani** - Company Secretary & Compliance Officer<BR>3. **Barkha Balkrushnan Deshmukh** - Independent Director<BR>4. **Viraj Samirbhai Shah** - Whole-time Director<BR>5. **Sunil Kondiba Kalhapure** - Independent Director<BR>6. **Rajasvee Shah** - Non-Executive Director<BR><BR>If you need more information about any specific member or their roles, feel free to ask!

Who are the peers of the ZR2 Bioenergy?

ZR2 Bioenergy's peers include Lords Chloro, Alufluoride, National Perox., Hind.Organ.Chem., Genus Prime, Kesar Petroprod., IVP, Kanchi Karpooram, and ARCL Organics. ZR2 Bioenergy has below-average management and growth ratings, with a 1-year return of -68.86%, the lowest among its peers.

Peers: The peers of ZR2 Bioenergy are Lords Chloro, Alufluoride, National Perox., Hind.Organ.Chem., Genus Prime, Kesar Petroprod., IVP, Kanchi Karpooram, and ARCL Organics.<BR><BR>Quality Snapshot: Excellent management risk is observed at Alufluoride and ARCL Organics, while Average management risk is found at Lords Chloro, Kesar Petroprod., and IVP, and the rest. Below Average management risk is seen at Hind.Organ.Chem., Genus Prime, and ZR2 Bioenergy, while Average growth is noted at Lords Chloro, Alufluoride, Kesar Petroprod., and IVP, and the rest. Below Average growth is present at Hind.Organ.Chem., ZR2 Bioenergy, and the rest, while Good growth is observed at Alufluoride, Kesar Petroprod., and Genus Prime. Capital Structure ratings show Excellent at Kanchi Karpooram, Good at Alufluoride and ARCL Organics, Average at Lords Chloro, Kesar Petroprod., and IVP, and Below Average at National Perox., Hind.Organ.Chem., Genus Prime, ZR2 Bioenergy, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Alufluoride at 13.80%, while ZR2 Bioenergy has the lowest at -68.86%. ZR2 Bioenergy's 1-year return is significantly worse than its peers. Additionally, the peers with negative six-month returns include Lords Chloro, ZR2 Bioenergy, Kesar Petroprod., Kanchi Karpooram, and ARCL Organics.

What does ZR2 Bioenergy do?

ZR2 Bioenergy Ltd is a micro-cap company in the commodity chemicals industry, established in 1911 and currently reporting a market cap of INR 217 Cr with a P/E ratio of 210.00 and a recent net profit of 0 Cr as of March 2026.

Overview: <BR>ZR2 Bioenergy Ltd operates in the commodity chemicals industry and is classified as a micro-cap company.<BR><BR>History: <BR>ZR2 Bioenergy Ltd was initially established in 1911 and underwent several name changes, becoming a Private Limited Company in 1939 as Sardesai Brothers Private Limited, then a Public Limited Company in 1961 as Sardesai Brothers Limited, and later renamed Gujchem Distillers India Limited in 1974. The latest quarterly results reported are for March 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: 0 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 217 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 210.00 <BR>Industry P/E: 42 <BR>Dividend Yield: 0.02% <BR>Debt-Equity: -0.13 <BR>Return on Equity: 0.72% <BR>Price-to-Book: 1.55 <BR><BR>Contact Details: <BR>Address: No 6 2nd Flr National Chambers, Nr City Gold Ashram Road Ahmedabad Gujarat : 380009 <BR>Tel: 91-7926580893 <BR>Email: gujcheminvestors@gmail.com <BR>Website: http://www.gujchemdistillers.com

When is the next results date for ZR2 Bioenergy Ltd?

The next results date for ZR2 Bioenergy Ltd is 29 May 2026.

The next results date for ZR2 Bioenergy Ltd is scheduled for 29 May 2026.

How has been the historical performance of ZR2 Bioenergy?

ZR2 Bioenergy's historical performance from March 2022 to March 2025 shows increased net sales and operating income, but a decline in profitability and operational efficiency, with profit after tax dropping significantly and operating profit margin turning negative. Despite stable liabilities and positive cash flow from operations, the company faced challenges in maintaining profitability.

Answer:<BR>The historical performance of ZR2 Bioenergy shows a mixed trend in financial metrics from March 2022 to March 2025.<BR><BR>Breakdown:<BR>ZR2 Bioenergy's net sales increased from 1.16 Cr in March 2022 to 1.49 Cr in March 2025, while total operating income also rose to 1.49 Cr from 1.16 Cr during the same period. However, the company's total expenditure saw a significant rise from 1.11 Cr to 1.90 Cr, leading to an operating profit (PBDIT) decline from 0.32 Cr to 0.23 Cr. The operating profit margin (excluding other income) fell sharply from 4.31% to -27.52%, indicating a deterioration in operational efficiency. Profit before tax decreased from 0.32 Cr to 0.20 Cr, and profit after tax dropped significantly from 0.39 Cr to 0.09 Cr, resulting in a PAT margin decline from 33.62% to 6.04%. On the balance sheet, total liabilities remained stable at 139.50 Cr, with shareholder's funds at 139.34 Cr. The cash flow from operating activities was positive at 31.00 Cr, while cash flow from investing activities was negative at -116.00 Cr, and financing activities contributed 100.00 Cr, leading to a net cash inflow of 14.00 Cr and a closing cash balance of 19.00 Cr. Overall, while sales and income showed growth, profitability and operational efficiency faced challenges.

Should I buy, sell or hold ZR2 Bioenergy?

Are ZR2 Bioenergy latest results good or bad?

ZR2 Bioenergy's latest results show improved profitability with a Profit After Tax increase, but net sales remain flat and operational challenges persist, leading to a 'Sell' rating from analysts. Overall, the results are mixed, indicating both positive and negative aspects.

ZR2 Bioenergy's latest results present a mixed picture. On one hand, the company has shown a significant improvement in profitability, with Profit After Tax (PAT) rising to Rs 0.42 crore for the latest six-month period, a substantial increase from Rs 0.06 crore in the previous year. This indicates that the company is on a positive trajectory in terms of profitability.<BR><BR>However, the overall financial performance remains flat, with net sales showing no growth compared to the previous year. Additionally, the Debtors Turnover Ratio has declined to 0.00 times, suggesting challenges in the company's ability to manage its debts effectively. This raises concerns about operational efficiency.<BR><BR>Furthermore, the stock is currently rated as a 'Sell' by MarketsMOJO, which reflects a cautious outlook from market analysts. Overall, while there are positive signs in profitability, the lack of growth in sales and operational challenges indicate that the results are not entirely favorable.

Who are the top shareholders of the ZRZ Bioenergy?

The top shareholders of ZRZ Bioenergy are Zr2 Group Holdings Ltd with 60.96% of shares, followed by public shareholder Manish Ruparel at 9.92%. Individual investors collectively own 37.43%, with no mutual funds or foreign institutional investors involved.

The top shareholders of ZRZ Bioenergy include Zr2 Group Holdings Ltd, which holds a significant 60.96% of the shares. Additionally, the highest public shareholder is Manish Ruparel, who owns 9.92%. Individual investors collectively hold 37.43% of the company's shares. There are currently no mutual funds or foreign institutional investors (FIIs) involved in the company's shareholding.

Is ZRZ Bioenergy overvalued or undervalued?

As of February 14, 2025, ZRZ Bioenergy is considered risky and overvalued with a PE ratio of -146.27 and significant financial distress, contrasting sharply with peers like Godrej Industries and Deepak Nitrite, despite having outperformed the Sensex over the past year.

As of 14 February 2025, the valuation grade for ZRZ Bioenergy has moved from very expensive to risky. The company is currently assessed as overvalued. Key ratios reveal a PE ratio of -146.27, an EV to EBITDA of -127.26, and a Price to Book Value of 1.05, indicating significant financial distress and a lack of profitability.<BR><BR>In comparison to its peers, ZRZ Bioenergy's valuation metrics starkly contrast with companies like Godrej Industries, which has a PE ratio of 46.63 and an EV to EBITDA of 34.36, and Deepak Nitrite, with a PE of 37.97 and an EV to EBITDA of 24.57. The substantial differences in these ratios highlight the challenges ZRZ Bioenergy faces within the commodity chemicals sector. Additionally, while ZRZ Bioenergy has outperformed the Sensex over the past year with a return of 87.11% compared to the Sensex's 7.65%, the underlying valuation suggests that this performance may not be sustainable given its current financial metrics.

What is the technical trend for ZRZ Bioenergy?

As of May 28, 2025, ZRZ Bioenergy shows a mildly bullish trend supported by the weekly MACD and Bollinger Bands, despite mixed signals from daily moving averages and the monthly MACD.

As of 28 May 2025, the technical trend for ZRZ Bioenergy has changed from sideways to mildly bullish. The weekly MACD is bullish, supporting the positive outlook, while the monthly MACD is mildly bearish, indicating some caution. The Bollinger Bands are bullish on both weekly and monthly time frames, reinforcing the upward momentum. However, daily moving averages are mildly bearish, suggesting short-term weakness. The KST is mildly bullish on the weekly and mildly bearish on the monthly, adding to the mixed signals. Dow Theory indicates a mildly bullish stance on both weekly and monthly charts. Overall, the current technical stance is mildly bullish, driven primarily by the weekly MACD and Bollinger Bands.

Has ZRZ Bioenergy declared dividend?

No Dividend History Available